FDA Inspection 1089541 — The Ritedose Corporation
The FDA completed an inspection of The Ritedose Corporation on April 18, 2019 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, SC (United States)
Additional Details
Bioanalytical BA/BE